FDA Brief

Warning letters Devices

FDA warning letter to

Bioptimal International

Issued Apr 3, 2024Posted May 7, 2024"OHT2: Office of Cardiovascular Devices, Office of Product Evaluation and Quality"

CGMP/QSR/Medical Devices/Adulterated. We haven't summarized this letter yet. Read it on fda.gov.